SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Debt | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr | ₹5.62 Cr |
What is the latest Total Debt ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Debt |
---|---|
Mar2024 | ₹72 Cr |
Mar2023 | ₹83 Cr |
Mar2022 | ₹58 Cr |
Mar2017 | ₹12 Cr |
Mar2016 | ₹5.62 Cr |
How is Total Debt of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹72 Cr | -12.86 | |
Mar2023 | ₹83 Cr | 43.94 | |
Mar2022 | ₹58 Cr | 364.15 | |
Mar2017 | ₹12 Cr | 121.47 | |
Mar2016 | ₹5.62 Cr | - |
Compare Total Debt of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,021.0 Cr | 0.3% | 26.8% | 81% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 0.3% |
26.8% |
81% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses